Intelliseq Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 17

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $4.63M

  • Investors
  • 8

Intelliseq General Information

Description

Developer of genome informatics designed to provide development in pharmacogenomics and transcriptomics. The company's services include creating novel algorithms and bioinformatics tools to assist in next-generation sequencing, data analysis, bioinformatics, and consulting, enabling scientific researchers to develop the diagnosis process.

Contact Information

Website
www.intelliseq.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Stanislawa Konarskiego street 42/13
  • Krakow, 30-046
  • Poland
+48 696
Primary Industry
Discovery Tools (Healthcare)
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Stanislawa Konarskiego street 42/13
  • Krakow, 30-046
  • Poland
+48 696

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Intelliseq Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 06-Feb-2025 $4.63M Completed Generating Revenue
6. Later Stage VC 07-Oct-2022 Completed Generating Revenue
5. Accelerator/Incubator 12-Jul-2021 Completed Generating Revenue
4. Later Stage VC 15-Feb-2021 Completed Generating Revenue
3. Accelerator/Incubator 19-May-2019 Completed Generating Revenue
2. Grant 24-Sep-2018 $4.41M $451K Completed Generating Revenue
1. Early Stage VC 01-Jan-2018 $451K $451K Completed Generating Revenue
To view Intelliseq’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Intelliseq Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Intelliseq Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Vinci (Warsaw) Venture Capital Minority
CobinAngels Angel Group Minority
YouNick Mint Venture Capital Minority
Google Accelerator Accelerator/Incubator
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Intelliseq FAQs

  • When was Intelliseq founded?

    Intelliseq was founded in 2014.

  • Where is Intelliseq headquartered?

    Intelliseq is headquartered in Krakow, Poland.

  • What is the size of Intelliseq?

    Intelliseq has 17 total employees.

  • What industry is Intelliseq in?

    Intelliseq’s primary industry is Discovery Tools (Healthcare).

  • Is Intelliseq a private or public company?

    Intelliseq is a Private company.

  • What is Intelliseq’s current revenue?

    The current revenue for Intelliseq is .

  • How much funding has Intelliseq raised over time?

    Intelliseq has raised $6.83M.

  • Who are Intelliseq’s investors?

    , Vinci (Warsaw), CobinAngels, YouNick Mint, and Google Accelerator are 5 of 8 investors who have invested in Intelliseq.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process